NPI: 1053389536 · TAMPA, FL 33607 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/09/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/09/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 18,621 | $2.39M |
| 2019 | 42,393 | $4.13M |
| 2020 | 13,376 | $842K |
| 2021 | 15,864 | $571K |
| 2022 | 855 | $67K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 24,471 | 1,623 | $2.23M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 26,066 | 1,006 | $2.11M |
| J1270 | Injection, doxercalciferol, 1 mcg | 20,612 | 1,202 | $1.54M |
| A4657 | Syringe, with or without needle, each | 4,554 | 1,446 | $921K |
| J1756 | Injection, iron sucrose, 1 mg | 5,093 | 855 | $380K |
| 83540 | 1,701 | 1,039 | $144K | |
| 85041 | 1,566 | 1,000 | $131K | |
| 85048 | 1,549 | 988 | $131K | |
| 82728 | 1,093 | 687 | $111K | |
| 83970 | 1,717 | 783 | $111K | |
| 83550 | 1,063 | 676 | $102K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 428 | 298 | $43K |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 810 | 197 | $17K |
| 82108 | 147 | 96 | $14K | |
| G0008 | Administration of influenza virus vaccine | 92 | 60 | $7K |
| 90674 | 52 | 34 | $7K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 79 | 25 | $6K |
| 90662 | 16 | 12 | $2K |